Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2005

A Comparison of the Efficacy of Dexamethasone and Loteprednol on Endotoxin–Induced Uveitis in Rodents Following Topical Ocular Administration

K. Phillips; H.R. Katz

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):983.

ARVO Annual Meeting Abstract May 2005

Human Aqueous Concentrations of Moxifloxacin and Gatifloxacin Following Two Multiple–Dose Topical Ocular Dosing Regimens With VIGAMOXTM and ZYMARTM

H.R. Katz; S. Lane; S. Masket; K. Sall; S. Orr; R. Faulkner; S.M. Robertson; D.C. Dahlin

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4907.

ARVO Annual Meeting Abstract May 2004

Human Aqueous Humor Concentrations of Moxifloxacin Following Two Multiple–Dose Topical Ocular Dosing Regimens of Vigamox®.

H.R. Katz; S. Lane; S. Masket; K. Sall; S. Orr; M. Curtis; R. Faulkner; D.C. Dahlin

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4926.

ARVO Annual Meeting Abstract May 2003

Moxifloxacin Ophthalmic Solution 0.5% Hastens Cure and Eradicates the Causative Pathogens of Bacterial Conjunctivitis in Pediatric and Adult Patients

H.R. Katz; W. Andrews; D. Creager; J. De Leon; K. Merkley; L. Gower; D.W. Stroman; N. Nicholson; S. Potts; Moxifloxacin Study Group

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):2114.

ARVO Annual Meeting Abstract May 2003

Comparison of Topical Moxifloxacin 0.5% to Ciprofloxacin 0.3% in the Treatment of Experimental Pseudomonas aeruginosa Keratitis in Rabbits

E.T. Aliprandis; J. Ciralsky; H. Lai; I. Herling; H.R. Katz

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4762.

Advertisement